What actually happens behind one sourced comparator product

A comparator product may appear to move through the clinical trial supply chain as a single shipment.

But behind that product is often a highly coordinated operational process involving sourcing teams, logistics specialists, regulatory experts, packaging providers, customs coordination, and site delivery planning across multiple regions.

In modern global clinical trials, even a single sourced comparator product may move through multiple operational stages before reaching a clinical trial site.

That complexity is one of the reasons comparator sourcing has become increasingly tied to operational planning, regulatory coordination, and study continuity across global clinical development.

Step 1: Identifying and sourcing the product

The process often begins with identifying where a comparator product is commercially available and whether sufficient inventory exists within the required market.

That may sound straightforward, but availability can vary significantly between regions due to:

In some cases, sourcing teams may need to identify alternative markets entirely in order to maintain continuity across the study lifecycle.

That introduces additional operational considerations around:

Growing global clinical trial activity is increasing competition for product availability across many international markets.

Step 2: Regulatory coordination and approvals

Once a sourcing route is identified, regulatory and operational coordination often begins across multiple regions and stakeholders.

Requirements can vary depending on:

Documentation, approvals, and compliance requirements may all need alignment before product movement can begin.

That can involve:

Even relatively small documentation delays can affect broader timelines if approvals do not align correctly across the operational process.

Step 3: Relabeling and packaging

Many comparator products also require relabeling or packaging adjustments before shipment.

For global studies, products may need:

Those changes must align with local regulations while maintaining product integrity and operational consistency across the study.

Packaging also becomes increasingly important for products requiring temperature-controlled transportation or extended transit times across multiple regions.

At this stage, coordination between sourcing, packaging, quality, logistics, and regulatory teams becomes particularly important.

Step 4: Customs and transportation planning

Once products are prepared for shipment, transportation planning introduces another layer of coordination complexity.

Comparator products moving across international borders may require:

Global clinical trial logistics environments can also be affected by:

That means shipment planning often requires significant operational visibility across the entire supply chain process.

Even small transportation delays can create downstream pressure on study timelines and site delivery schedules.

Step 5: Site delivery and operational continuity

The final delivery stage may appear to be the simplest part of the process.

But maintaining continuity through final site delivery often depends on every previous operational stage aligning correctly.

That includes:

If disruption occurs earlier in the process, operational pressure can quickly escalate across the broader study environment.

This is one of the reasons sourcing visibility and earlier operational planning are becoming increasingly important across modern global clinical trials.

Comparator sourcing is an operational process

Comparator sourcing is often viewed externally as a procurement activity focused on obtaining product.

In reality, the process involves significant operational coordination across sourcing, logistics, packaging, regulatory, quality, and clinical trial supply teams.

A single comparator product may move through multiple countries, operational checkpoints, compliance processes, and transportation stages before reaching a patient-facing clinical trial environment.

That level of coordination requires:

Operational visibility throughout the sourcing process is now closely tied to continuity, flexibility, and execution timelines across global clinical trials.

Looking ahead

Modern clinical development operates within increasingly interconnected global supply and operational environments.

For sourcing teams, that means comparator strategy increasingly depends on:

What appears externally as a single sourced product often reflects a highly coordinated operational system working behind the scenes.

And as global trial complexity continues to increase, that level of coordination is now a critical part of successful clinical trial execution.